0

Santen Pharmaceutical Co Ltd (4536) – Financial and Strategic SWOT Analysis Review

Publisher Name :
Date: 15-Mar-2017
No. of pages: 46

Santen Pharmaceutical Co Ltd (4536) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

– Business description – A detailed description of the company’s operations and business divisions.
– Corporate strategy – Analyst’s summarization of the company’s business strategy.
– SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
– Company history – Progression of key events associated with the company.
– Major products and services – A list of major products, services and brands of the company.
– Key competitors – A list of key competitors to the company.
– Key employees – A list of the key executives of the company.
– Executive biographies – A brief summary of the executives’ employment history.
– Key operational heads – A list of personnel heading key departments/functions.
– Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities – A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Santen Pharmaceutical Co Ltd (Santen) is a pharmaceutical company. It focuses on the development and manufacture of pharmaceutical products and medical devices. Santen specializes in ophthalmological products. Its product portfolio includes prescription ophthalmic products, anti-rheumatics, OTC drugs, anti-allergy ophthalmic products, prescription anti-rheumatic drugs and medical devices such as intraocular lenses, among others. The company markets its products under brand names such as Livostin, Alesion, Metadate, Cravit, Diquas and Hyalein, among others. It has manufacturing plants and laboratories in France, Japan, China, Finland and the US. The company markets its products in over 50 countries. Santen is headquartered in Osaka, Japan.

Santen Pharmaceutical Co Ltd Key Recent Developments

Feb 07, 2017: Santen Pharma Reports Revenue Of JPY150.7 Billion In Nine Months Ended December 31, 2016
Nov 02, 2016: Santen Consolidated Results for Q2 Fiscal 2016
Oct 03, 2016: Santen: Personnel Changes of Corporate Officer
May 11, 2016: Santen Reports Fiscal 2015 Consolidated Performance
Feb 02, 2016: Santen Pharma Reports Revenue Of JPY149.2 Billion In Nine Months Ended December 31, 2015

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
– The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
– The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
– Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
– Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
– Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of content
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Santen Pharmaceutical Co Ltd - Key Facts 6
Santen Pharmaceutical Co Ltd - Key Employees 7
Santen Pharmaceutical Co Ltd - Major Products and Services 8
Santen Pharmaceutical Co Ltd - Pharmaceutical Pipeline Products Data 9
Santen Pharmaceutical Co Ltd, Pipeline Products by Therapy Area 9
Santen Pharmaceutical Co Ltd, Pipeline Products by Development Phase 10
Santen Pharmaceutical Co Ltd - History 11
Santen Pharmaceutical Co Ltd - Company Statement 17
Santen Pharmaceutical Co Ltd - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Section 2 - Company Analysis 21
Santen Pharmaceutical Co Ltd - Business Description 21
Santen Pharmaceutical Co Ltd - Corporate Strategy 22
Santen Pharmaceutical Co Ltd - SWOT Analysis 23
SWOT Analysis - Overview 23
Santen Pharmaceutical Co Ltd - Strengths 23
Santen Pharmaceutical Co Ltd - Weaknesses 24
Santen Pharmaceutical Co Ltd - Opportunities 25
Santen Pharmaceutical Co Ltd - Threats 26
Santen Pharmaceutical Co Ltd - Key Competitors 27
Section 3 - Company Financial Ratios 28
Financial Ratios - Capital Market Ratios 28
Financial Ratios - Annual Ratios 29
Performance Chart 31
Financial Performance 31
Financial Ratios - Interim Ratios 32
Financial Ratios - Ratio Charts 33
Section 4 - Company's Lifesciences Financial Deals and Alliances 34
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 34
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 35
Santen Pharmaceutical Co Ltd, Recent Deals Summary 36
Section 5 - Company's Recent Developments 37
Feb 07, 2017: Santen Pharma Reports Revenue Of JPY150.7 Billion In Nine Months Ended December 31, 2016 37
Nov 02, 2016: Santen Consolidated Results for Q2 Fiscal 2016 38
Oct 03, 2016: Santen: Personnel Changes of Corporate Officer 39
May 11, 2016: Santen Reports Fiscal 2015 Consolidated Performance 40
Feb 02, 2016: Santen Pharma Reports Revenue Of JPY149.2 Billion In Nine Months Ended December 31, 2015 41
Section 6 - Appendix 42
Methodology 42
Ratio Definitions 42
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Santen Pharmaceutical Co Ltd, Key Facts 6
Santen Pharmaceutical Co Ltd, Key Employees 7
Santen Pharmaceutical Co Ltd, Major Products and Services 8
Santen Pharmaceutical Co Ltd, Number of Pipeline Products by Therapy Area 9
Santen Pharmaceutical Co Ltd, Number of Pipeline Products by Development Stage 10
Santen Pharmaceutical Co Ltd, History 11
Santen Pharmaceutical Co Ltd, Other Locations 18
Santen Pharmaceutical Co Ltd, Subsidiaries 19
Santen Pharmaceutical Co Ltd, Key Competitors 27
Santen Pharmaceutical Co Ltd, Ratios based on current share price 28
Santen Pharmaceutical Co Ltd, Annual Ratios 29
Santen Pharmaceutical Co Ltd (Cont...1), Annual Ratios 30
Santen Pharmaceutical Co Ltd, Interim Ratios 32
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 34
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 35
Santen Pharmaceutical Co Ltd, Recent Deals Summary 36
Currency Codes 42
Capital Market Ratios 42
Equity Ratios 43
Profitability Ratios 43
Cost Ratios 44
Liquidity Ratios 44
Leverage Ratios 44
Efficiency Ratios 45

List of Figures
Santen Pharmaceutical Co Ltd, Pipeline Products by Therapy Area 9
Santen Pharmaceutical Co Ltd, Pipeline Products by Development Phase 10
Santen Pharmaceutical Co Ltd, Performance Chart (2012 - 2016) 31
Santen Pharmaceutical Co Ltd, Ratio Charts 33
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 34
Santen Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 35

News

  • Understanding the Need For Travel Vaccination
  • If you are getting ready for a particular trip that can see you away from your house for about a month or so, then it is necessary for you to take the help of travel vaccinations. Not ...
  • The Work Of The Ophthalmology Specialist
  • When we consider ophthalmology as a branch of science, it is actually about the treatment as well as getting to diagnose the different kinds of diseases and the disorder that is to ...
  • The Process Of Dental Implants And The Subsequent Recovery
  • In the United States of America, the fear of going to a dentist happens to rank number one on the list of children as well as adults. Most of the people are actually concerned when ...
  • The medication that can help the rural population
  • It is not always that you get to see world class hospitals in the rural areas, be it America or any other country. Hence, it is important that people actually take the help of tele-medication, ...
  • The Future of Telemedicine & Its Use
  • When talking about telemedicine, you do get to realize that it is the healthcare of the future. Most of the people do not realize the implications, and for more so the time, telemedicine ...

Get Updates

Share This Post

Recent Posts

© 2017 RnR Company Profiles. All rights reserved.